Sophia Delicou: A Shift Toward Function-Centered Care for Patients with Hemoglobinopathies
Sophia Delicou, Head of Thalassemia and Sickle Cell Unit, Head of the Expertise Center of Hemoglobin Diseases and Their Complications at Hippokrateio General Hospital, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Mediterranean Journal of Hematology and Infectious Diseases, adding:
“New Publication Announcement!
I’m pleased to share our latest publication in the Mediterranean Journal of Hematology and Infectious Diseases.
Our work explores the emerging challenge of aging in patients with thalassemia and sickle cell disease, proposing a gerontological framework to better understand and manage the growing population of adults living beyond midlife with these conditions.
Key insights:
- Hemoglobinopathies are increasingly becoming lifelong chronic conditions, with more patients reaching their 50s and beyond
- There is a shift from acute, disease-centered care to managing multimorbidity and functional decline
- Clinical priorities should include frailty, cognition, quality of life, and patient-centered outcomes
- Multidisciplinary and integrated care models are essential for optimal long-term management
This work highlights the need to rethink traditional care models and align them with the realities of aging with complex chronic diseases.
Grateful to collaborate with such a dedicated multidisciplinary team.”
Title: Aging with thalassemia and sickle cell disease: A gerontological model of accelerated multimorbidity and function-centered care beyond midlife
Authors: Sophia Delicou, Ioannis Ilias, Athanasia Kapota, Elena Papatheodorou, Maria Moraki, Aikaterini Xydaki, Alexandra Mika, Panagiota Giannou, Irene Kouroukli, Theodoros Aforozis, Myrto Palkopoulou, Christos Savvidis, Iliana Mani, Constantina Aggeli, John Koskinas
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 28, 2026, 19:05Jack Shuang Hou: Novo Nordisk to Present New Haemophilia Data on Investigational Denecimig at ISTH 2026
-
Jun 28, 2026, 19:05Pinar Demirtepe: Not All “Blood Thinners” Are the Same
-
Jun 28, 2026, 19:05Andrea Cesari: Comparing Catheter-Based Reperfusion Strategies for Intermediate-High-Risk PE
-
Jun 28, 2026, 19:02Nassim Emteir: Interpreting TSAT with Ferritin to Guide Iron Deficiency Diagnosis and Treatment
-
Jun 28, 2026, 19:00Andrew Jackson: Predicting PICC-Related Venous Thrombosis in Patients Undergoing Radiotherapy
-
Jun 28, 2026, 10:34Heghine Khachatryan: Menarche as the First ‘Bleeding Challenge’
-
Jun 28, 2026, 10:13Mohammed Alharbi: Assessing Warfarin Management and Anticoagulation Quality in Older Populations
-
Jun 28, 2026, 10:03Rick Kapur: Current Understanding of FNAIT Regarding Diagnostics, Pathophysiology and Management
-
Jun 28, 2026, 09:55Utkarsh Pandey: Japan Approves Wayrilz for ITP Patients